Hotline: +86-18022463983    020-85206863

Login Regiser

Global Synthetic Peptide Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Published Date: 2025-08-07   |   Pages: 79   |   Tables: 77   |  Pharma & Healthcare

The global Synthetic Peptide Vaccine market size was US$ 115 million in 2024 and is forecast to a readjusted size of US$ 189 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Synthetic Peptide Vaccine market competitiveness, regional economic performance, and supply chain configurations.
Synthetic peptide vaccines represent fragments of protein antigen sequences, synthesizing specific B cell and T cell epitopes offer the potential to induce diseases neutralizing immuno response with completely synthetic structure. Now it is well established that short chain peptides can be used to mimic antigenic sites of viruses and thus can be used the basics for vaccines and development.
Synthetic peptide vaccine is the most ideal and safe new vaccine, and it is also one of the main directions for the development of new vaccines for the prevention and control of infectious diseases and malignant tumors.
Currently, synthetic peptide vaccines for human use are all in the research and development/trial stage, and the only commercially available vaccines are for veterinary use, mainly swine foot-and-mouth disease vaccines.
According to the type, the classification of Synthetic Peptide Vaccine includes FMD Type O, FMD Type O+A, etc. In 2024, FMD Type O Synthetic Peptide Vaccine accounted for a share of 48% in the global Synthetic Peptide Vaccine market.
Synthetic Peptide Vaccine is purchased by Government Procurement or Direct Sales. In Synthetic Peptide Vaccine market, the Government Procurement holds an important share in terms of Application. China is the largest consumption place, with a revenue market share nearly 85%.
The market is highly concentrated. Major manufacturers are United Biomedical, CAHIC, and Xinjiang Tecon. Among them, United Biomedical is the largest manufacturer, with a revenue share of 51%.
The global Synthetic Peptide Vaccine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
United Biomedical
CAHIC
Xinjiang Tecon
ISA Pharmaceuticals
Lytix Biopharma
Merck
OncoTherapy Science
Circio
Stemline Therapeutics
Treos Bio
By Type: (Dominant Segment vs High-Margin Innovation)
FMD Type O
FMD Type O+A
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Government Procurement
Direct Sales
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., United Biomedical in Europe)
- Emerging Product Trends: FMD Type O adoption vs. FMD Type O+A premiumization
- Demand-Side Dynamics: Government Procurement growth in China vs. Direct Sales potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Synthetic Peptide Vaccine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., FMD Type O+A in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Direct Sales in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., FMD Type O dominance in Europe vs. FMD Type O+A demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Market Overview
1.1 Synthetic Peptide Vaccine Product Scope
1.2 Synthetic Peptide Vaccine by Type
1.2.1 Global Synthetic Peptide Vaccine Sales by Type (2020 & 2024 & 2031)
1.2.2 FMD Type O
1.2.3 FMD Type O+A
1.2.4 Others
1.3 Synthetic Peptide Vaccine by Application
1.3.1 Global Synthetic Peptide Vaccine Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Government Procurement
1.3.3 Direct Sales
1.4 Global Synthetic Peptide Vaccine Market Estimates and Forecasts (2020-2031)
1.4.1 Global Synthetic Peptide Vaccine Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Synthetic Peptide Vaccine Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Synthetic Peptide Vaccine Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Synthetic Peptide Vaccine Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Synthetic Peptide Vaccine Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Synthetic Peptide Vaccine Sales Market Share by Region (2020-2025)
2.2.2 Global Synthetic Peptide Vaccine Revenue Market Share by Region (2020-2025)
2.3 Global Synthetic Peptide Vaccine Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Synthetic Peptide Vaccine Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Synthetic Peptide Vaccine Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Synthetic Peptide Vaccine Market Size and Prospective (2020-2031)
2.4.2 Europe Synthetic Peptide Vaccine Market Size and Prospective (2020-2031)
2.4.3 China Synthetic Peptide Vaccine Market Size and Prospective (2020-2031)
2.4.4 Japan Synthetic Peptide Vaccine Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Synthetic Peptide Vaccine Historic Market Review by Type (2020-2025)
3.1.1 Global Synthetic Peptide Vaccine Sales by Type (2020-2025)
3.1.2 Global Synthetic Peptide Vaccine Revenue by Type (2020-2025)
3.1.3 Global Synthetic Peptide Vaccine Price by Type (2020-2025)
3.2 Global Synthetic Peptide Vaccine Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Synthetic Peptide Vaccine Sales Forecast by Type (2026-2031)
3.2.2 Global Synthetic Peptide Vaccine Revenue Forecast by Type (2026-2031)
3.2.3 Global Synthetic Peptide Vaccine Price Forecast by Type (2026-2031)
3.3 Different Types Synthetic Peptide Vaccine Representative Players
4 Global Market Size by Application
4.1 Global Synthetic Peptide Vaccine Historic Market Review by Application (2020-2025)
4.1.1 Global Synthetic Peptide Vaccine Sales by Application (2020-2025)
4.1.2 Global Synthetic Peptide Vaccine Revenue by Application (2020-2025)
4.1.3 Global Synthetic Peptide Vaccine Price by Application (2020-2025)
4.2 Global Synthetic Peptide Vaccine Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Synthetic Peptide Vaccine Sales Forecast by Application (2026-2031)
4.2.2 Global Synthetic Peptide Vaccine Revenue Forecast by Application (2026-2031)
4.2.3 Global Synthetic Peptide Vaccine Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Synthetic Peptide Vaccine Application
5 Competition Landscape by Players
5.1 Global Synthetic Peptide Vaccine Sales by Players (2020-2025)
5.2 Global Top Synthetic Peptide Vaccine Players by Revenue (2020-2025)
5.3 Global Synthetic Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Peptide Vaccine as of 2024)
5.4 Global Synthetic Peptide Vaccine Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Synthetic Peptide Vaccine, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Synthetic Peptide Vaccine, Product Type & Application
5.7 Global Key Manufacturers of Synthetic Peptide Vaccine, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Synthetic Peptide Vaccine Sales by Company
6.1.1.1 North America Synthetic Peptide Vaccine Sales by Company (2020-2025)
6.1.1.2 North America Synthetic Peptide Vaccine Revenue by Company (2020-2025)
6.1.2 North America Synthetic Peptide Vaccine Sales Breakdown by Type (2020-2025)
6.1.3 North America Synthetic Peptide Vaccine Sales Breakdown by Application (2020-2025)
6.1.4 North America Synthetic Peptide Vaccine Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Synthetic Peptide Vaccine Sales by Company
6.2.1.1 Europe Synthetic Peptide Vaccine Sales by Company (2020-2025)
6.2.1.2 Europe Synthetic Peptide Vaccine Revenue by Company (2020-2025)
6.2.2 Europe Synthetic Peptide Vaccine Sales Breakdown by Type (2020-2025)
6.2.3 Europe Synthetic Peptide Vaccine Sales Breakdown by Application (2020-2025)
6.2.4 Europe Synthetic Peptide Vaccine Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Synthetic Peptide Vaccine Sales by Company
6.3.1.1 China Synthetic Peptide Vaccine Sales by Company (2020-2025)
6.3.1.2 China Synthetic Peptide Vaccine Revenue by Company (2020-2025)
6.3.2 China Synthetic Peptide Vaccine Sales Breakdown by Type (2020-2025)
6.3.3 China Synthetic Peptide Vaccine Sales Breakdown by Application (2020-2025)
6.3.4 China Synthetic Peptide Vaccine Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Synthetic Peptide Vaccine Sales by Company
6.4.1.1 Japan Synthetic Peptide Vaccine Sales by Company (2020-2025)
6.4.1.2 Japan Synthetic Peptide Vaccine Revenue by Company (2020-2025)
6.4.2 Japan Synthetic Peptide Vaccine Sales Breakdown by Type (2020-2025)
6.4.3 Japan Synthetic Peptide Vaccine Sales Breakdown by Application (2020-2025)
6.4.4 Japan Synthetic Peptide Vaccine Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 United Biomedical
7.1.1 United Biomedical Company Information
7.1.2 United Biomedical Business Overview
7.1.3 United Biomedical Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.1.4 United Biomedical Synthetic Peptide Vaccine Products Offered
7.1.5 United Biomedical Recent Development
7.2 CAHIC
7.2.1 CAHIC Company Information
7.2.2 CAHIC Business Overview
7.2.3 CAHIC Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.2.4 CAHIC Synthetic Peptide Vaccine Products Offered
7.2.5 CAHIC Recent Development
7.3 Xinjiang Tecon
7.3.1 Xinjiang Tecon Company Information
7.3.2 Xinjiang Tecon Business Overview
7.3.3 Xinjiang Tecon Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Xinjiang Tecon Synthetic Peptide Vaccine Products Offered
7.3.5 Xinjiang Tecon Recent Development
7.4 ISA Pharmaceuticals
7.4.1 ISA Pharmaceuticals Company Information
7.4.2 ISA Pharmaceuticals Business Overview
7.4.3 ISA Pharmaceuticals Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.4.4 ISA Pharmaceuticals Synthetic Peptide Vaccine Products Offered
7.4.5 ISA Pharmaceuticals Recent Development
7.5 Lytix Biopharma
7.5.1 Lytix Biopharma Company Information
7.5.2 Lytix Biopharma Business Overview
7.5.3 Lytix Biopharma Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Lytix Biopharma Synthetic Peptide Vaccine Products Offered
7.5.5 Lytix Biopharma Recent Development
7.6 Merck
7.6.1 Merck Company Information
7.6.2 Merck Business Overview
7.6.3 Merck Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Merck Synthetic Peptide Vaccine Products Offered
7.6.5 Merck Recent Development
7.7 OncoTherapy Science
7.7.1 OncoTherapy Science Company Information
7.7.2 OncoTherapy Science Business Overview
7.7.3 OncoTherapy Science Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.7.4 OncoTherapy Science Synthetic Peptide Vaccine Products Offered
7.7.5 OncoTherapy Science Recent Development
7.8 Circio
7.8.1 Circio Company Information
7.8.2 Circio Business Overview
7.8.3 Circio Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Circio Synthetic Peptide Vaccine Products Offered
7.8.5 Circio Recent Development
7.9 Stemline Therapeutics
7.9.1 Stemline Therapeutics Company Information
7.9.2 Stemline Therapeutics Business Overview
7.9.3 Stemline Therapeutics Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Stemline Therapeutics Synthetic Peptide Vaccine Products Offered
7.9.5 Stemline Therapeutics Recent Development
7.10 Treos Bio
7.10.1 Treos Bio Company Information
7.10.2 Treos Bio Business Overview
7.10.3 Treos Bio Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Treos Bio Synthetic Peptide Vaccine Products Offered
7.10.5 Treos Bio Recent Development
8 Synthetic Peptide Vaccine Manufacturing Cost Analysis
8.1 Synthetic Peptide Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Synthetic Peptide Vaccine
8.4 Synthetic Peptide Vaccine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Synthetic Peptide Vaccine Distributors List
9.3 Synthetic Peptide Vaccine Customers
10 Synthetic Peptide Vaccine Market Dynamics
10.1 Synthetic Peptide Vaccine Industry Trends
10.2 Synthetic Peptide Vaccine Market Drivers
10.3 Synthetic Peptide Vaccine Market Challenges
10.4 Synthetic Peptide Vaccine Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer

List of Tables
Table 1. Global Synthetic Peptide Vaccine Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Synthetic Peptide Vaccine Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Synthetic Peptide Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Synthetic Peptide Vaccine Sales (M ml) by Region (2020-2025)
Table 5. Global Synthetic Peptide Vaccine Sales Market Share by Region (2020-2025)
Table 6. Global Synthetic Peptide Vaccine Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Synthetic Peptide Vaccine Revenue Share by Region (2020-2025)
Table 8. Global Synthetic Peptide Vaccine Sales (M ml) Forecast by Region (2026-2031)
Table 9. Global Synthetic Peptide Vaccine Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Synthetic Peptide Vaccine Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Synthetic Peptide Vaccine Revenue Share Forecast by Region (2026-2031)
Table 12. Global Synthetic Peptide Vaccine Sales by Type (M ml) & (2020-2025)
Table 13. Global Synthetic Peptide Vaccine Sales Share by Type (2020-2025)
Table 14. Global Synthetic Peptide Vaccine Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Synthetic Peptide Vaccine Price by Type (US$/L) & (2020-2025)
Table 16. Global Synthetic Peptide Vaccine Sales by Type (M ml) & (2026-2031)
Table 17. Global Synthetic Peptide Vaccine Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Synthetic Peptide Vaccine Price by Type (US$/L) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Synthetic Peptide Vaccine Sales by Application (M ml) & (2020-2025)
Table 21. Global Synthetic Peptide Vaccine Sales Share by Application (2020-2025)
Table 22. Global Synthetic Peptide Vaccine Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Synthetic Peptide Vaccine Price by Application (US$/L) & (2020-2025)
Table 24. Global Synthetic Peptide Vaccine Sales by Application (M ml) & (2026-2031)
Table 25. Global Synthetic Peptide Vaccine Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Synthetic Peptide Vaccine Price by Application (US$/L) & (2026-2031)
Table 27. New Sources of Growth in Synthetic Peptide Vaccine Application
Table 28. Global Synthetic Peptide Vaccine Sales by Company (M ml) & (2020-2025)
Table 29. Global Synthetic Peptide Vaccine Sales Share by Company (2020-2025)
Table 30. Global Synthetic Peptide Vaccine Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Synthetic Peptide Vaccine Revenue Share by Company (2020-2025)
Table 32. Global Synthetic Peptide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Peptide Vaccine as of 2024)
Table 33. Global Market Synthetic Peptide Vaccine Average Price by Company (US$/L) & (2020-2025)
Table 34. Global Key Manufacturers of Synthetic Peptide Vaccine, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Synthetic Peptide Vaccine, Product Type & Application
Table 36. Global Key Manufacturers of Synthetic Peptide Vaccine, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Synthetic Peptide Vaccine Sales by Company (2020-2025) & (M ml)
Table 39. North America Synthetic Peptide Vaccine Sales Market Share by Company (2020-2025)
Table 40. North America Synthetic Peptide Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Synthetic Peptide Vaccine Revenue Market Share by Company (2020-2025)
Table 42. North America Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml)
Table 43. North America Synthetic Peptide Vaccine Sales Market Share by Type (2020-2025)
Table 44. North America Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml)
Table 45. North America Synthetic Peptide Vaccine Sales Market Share by Application (2020-2025)
Table 46. Europe Synthetic Peptide Vaccine Sales by Company (2020-2025) & (M ml)
Table 47. Europe Synthetic Peptide Vaccine Sales Market Share by Company (2020-2025)
Table 48. Europe Synthetic Peptide Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Synthetic Peptide Vaccine Revenue Market Share by Company (2020-2025)
Table 50. Europe Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml)
Table 51. Europe Synthetic Peptide Vaccine Sales Market Share by Type (2020-2025)
Table 52. Europe Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml)
Table 53. Europe Synthetic Peptide Vaccine Sales Market Share by Application (2020-2025)
Table 54. China Synthetic Peptide Vaccine Sales by Company (2020-2025) & (M ml)
Table 55. China Synthetic Peptide Vaccine Sales Market Share by Company (2020-2025)
Table 56. China Synthetic Peptide Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Synthetic Peptide Vaccine Revenue Market Share by Company (2020-2025)
Table 58. China Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml)
Table 59. China Synthetic Peptide Vaccine Sales Market Share by Type (2020-2025)
Table 60. China Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml)
Table 61. China Synthetic Peptide Vaccine Sales Market Share by Application (2020-2025)
Table 62. Japan Synthetic Peptide Vaccine Sales by Company (2020-2025) & (M ml)
Table 63. Japan Synthetic Peptide Vaccine Sales Market Share by Company (2020-2025)
Table 64. Japan Synthetic Peptide Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Synthetic Peptide Vaccine Revenue Market Share by Company (2020-2025)
Table 66. Japan Synthetic Peptide Vaccine Sales by Type (2020-2025) & (M ml)
Table 67. Japan Synthetic Peptide Vaccine Sales Market Share by Type (2020-2025)
Table 68. Japan Synthetic Peptide Vaccine Sales by Application (2020-2025) & (M ml)
Table 69. Japan Synthetic Peptide Vaccine Sales Market Share by Application (2020-2025)
Table 70. United Biomedical Company Information
Table 71. United Biomedical Description and Business Overview
Table 72. United Biomedical Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 73. United Biomedical Synthetic Peptide Vaccine Product
Table 74. United Biomedical Recent Development
Table 75. CAHIC Company Information
Table 76. CAHIC Description and Business Overview
Table 77. CAHIC Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 78. CAHIC Synthetic Peptide Vaccine Product
Table 79. CAHIC Recent Development
Table 80. Xinjiang Tecon Company Information
Table 81. Xinjiang Tecon Description and Business Overview
Table 82. Xinjiang Tecon Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 83. Xinjiang Tecon Synthetic Peptide Vaccine Product
Table 84. Xinjiang Tecon Recent Development
Table 85. ISA Pharmaceuticals Company Information
Table 86. ISA Pharmaceuticals Description and Business Overview
Table 87. ISA Pharmaceuticals Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 88. ISA Pharmaceuticals Synthetic Peptide Vaccine Product
Table 89. ISA Pharmaceuticals Recent Development
Table 90. Lytix Biopharma Company Information
Table 91. Lytix Biopharma Description and Business Overview
Table 92. Lytix Biopharma Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 93. Lytix Biopharma Synthetic Peptide Vaccine Product
Table 94. Lytix Biopharma Recent Development
Table 95. Merck Company Information
Table 96. Merck Description and Business Overview
Table 97. Merck Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 98. Merck Synthetic Peptide Vaccine Product
Table 99. Merck Recent Development
Table 100. OncoTherapy Science Company Information
Table 101. OncoTherapy Science Description and Business Overview
Table 102. OncoTherapy Science Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 103. OncoTherapy Science Synthetic Peptide Vaccine Product
Table 104. OncoTherapy Science Recent Development
Table 105. Circio Company Information
Table 106. Circio Description and Business Overview
Table 107. Circio Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 108. Circio Synthetic Peptide Vaccine Product
Table 109. Circio Recent Development
Table 110. Stemline Therapeutics Company Information
Table 111. Stemline Therapeutics Description and Business Overview
Table 112. Stemline Therapeutics Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 113. Stemline Therapeutics Synthetic Peptide Vaccine Product
Table 114. Stemline Therapeutics Recent Development
Table 115. Treos Bio Company Information
Table 116. Treos Bio Description and Business Overview
Table 117. Treos Bio Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 118. Treos Bio Synthetic Peptide Vaccine Product
Table 119. Treos Bio Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Synthetic Peptide Vaccine Distributors List
Table 123. Synthetic Peptide Vaccine Customers List
Table 124. Synthetic Peptide Vaccine Market Trends
Table 125. Synthetic Peptide Vaccine Market Drivers
Table 126. Synthetic Peptide Vaccine Market Challenges
Table 127. Synthetic Peptide Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources


List of Figures
Figure 1. Synthetic Peptide Vaccine Product Picture
Figure 2. Global Synthetic Peptide Vaccine Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Synthetic Peptide Vaccine Sales Market Share by Type in 2024 & 2031
Figure 4. FMD Type O Product Picture
Figure 5. FMD Type O+A Product Picture
Figure 6. Others Product Picture
Figure 7. Global Synthetic Peptide Vaccine Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Synthetic Peptide Vaccine Sales Market Share by Application in 2024 & 2031
Figure 9. Government Procurement Examples
Figure 10. Direct Sales Examples
Figure 11. Global Synthetic Peptide Vaccine Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Synthetic Peptide Vaccine Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Synthetic Peptide Vaccine Sales (M ml) Growth Rate (2020-2031)
Figure 14. Global Synthetic Peptide Vaccine Price Trends Growth Rate (2020-2031) & (US$/L)
Figure 15. Synthetic Peptide Vaccine Report Years Considered
Figure 16. Global Market Synthetic Peptide Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Synthetic Peptide Vaccine Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Synthetic Peptide Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Synthetic Peptide Vaccine Sales (M ml) Growth Rate (2020-2031)
Figure 20. Europe Synthetic Peptide Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Synthetic Peptide Vaccine Sales (M ml) Growth Rate (2020-2031)
Figure 22. China Synthetic Peptide Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Synthetic Peptide Vaccine Sales (M ml) Growth Rate (2020-2031)
Figure 24. Japan Synthetic Peptide Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Synthetic Peptide Vaccine Sales (M ml) Growth Rate (2020-2031)
Figure 26. Global Synthetic Peptide Vaccine Revenue Share by Type (2020-2025)
Figure 27. Global Synthetic Peptide Vaccine Sales Share by Type (2026-2031)
Figure 28. Global Synthetic Peptide Vaccine Revenue Share by Type (2026-2031)
Figure 29. Global Synthetic Peptide Vaccine Revenue Share by Application (2020-2025)
Figure 30. Global Synthetic Peptide Vaccine Revenue Growth Rate by Application in 2020 & 2024
Figure 31. Global Synthetic Peptide Vaccine Sales Share by Application (2026-2031)
Figure 32. Global Synthetic Peptide Vaccine Revenue Share by Application (2026-2031)
Figure 33. Global Synthetic Peptide Vaccine Sales Share by Company (2024)
Figure 34. Global Synthetic Peptide Vaccine Revenue Share by Company (2024)
Figure 35. Global 5 Largest Synthetic Peptide Vaccine Players Market Share by Revenue in Synthetic Peptide Vaccine: 2020 & 2024
Figure 36. Synthetic Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 37. Manufacturing Cost Structure of Synthetic Peptide Vaccine
Figure 38. Manufacturing Process Analysis of Synthetic Peptide Vaccine
Figure 39. Synthetic Peptide Vaccine Industrial Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Distributors Profiles
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed

Our Clients